Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Erenumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amgen's Biologic Aimovig (Erenumab) Receives Approval in the U.S.
    Amgen's Biologic Aimovig (Erenumab) Receives Approval in the U.S.

    03 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

    FDA
    03 Oct 2022
    Share Share
    Amgen's Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.
    Amgen's Biologic Aimovig (Erenumab-Aooe) Receives Approval in the U.S.

    15 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761077

    FDA
    15 Aug 2022
    Share Share
    Novartis, Amgen settle their yearslong Aimovig dispute
    Novartis, Amgen settle their yearslong Aimovig dispute

    02 Feb 2022

    // E. Sagonowsky FIERCEPHARMA

    https://www.fiercepharma.com/pharma/novartis-amgen-settle-their-dueling-lawsuits-over-migraine-drug-aimovig

    E. Sagonowsky FIERCEPHARMA
    02 Feb 2022
    Share Share
    Aimovig displays superiority over topiramate in migraine study
    Aimovig displays superiority over topiramate in migraine study

    09 Nov 2021

    // Anna Begley EUROPEANPHARMACEUTICALREVIEW

    https://www.europeanpharmaceuticalreview.com/news/165242/aimovigdisplays-superiority-over-topiramate-in-migraine-study/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    09 Nov 2021
    Share Share
    AbbVie follows Biohaven into oral CGRP for migraine prevention
    AbbVie follows Biohaven into oral CGRP for migraine prevention

    29 Sep 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma/abbvie-pressures-biohaven-migraine-prevention-fda-approval-for-cgrp-blockbuster-to-be

    Angus Liu FIERCEPHARMA
    29 Sep 2021
    Share Share
    AbbVie's oral migraine treatment atogepant nears FDA decision
    AbbVie's oral migraine treatment atogepant nears FDA decision

    20 Aug 2021

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/migraine-market-better-make-way-for-abbvie-as-oral-preventative-treatment-atogepant-poised

    Annalee Armstrong FIERCEBIOTECH
    20 Aug 2021
    Share Share